The clinical relevance of FGF2, FGFBP1, TGFA, TGFBR3, and IGF1R expression was explored using the TIMER2.0 Gene Outcome Module adjusted by the clinical stage factors across various cancer types. This evidence concerns the gene TGFBR3 and cancer.